A Phase Ib study to determine the safety and immunogenicity of the candidate Middle East Res-piratory Syndrome Coronavirus (MERS-CoV) vaccine ChAdOx1 MERS in healthy adult Middle Eastern volunteers
2020-07-04
عنوان الدراسة
A Phase Ib study to determine the safety and immunogenicity of the candidate Middle East Res-piratory Syndrome Coronavirus (MERS-CoV) vaccine ChAdOx1 MERS in healthy adult Middle Eastern volunteers
داعم الدراسة
KAIMRC
دواء الدراسة
vaccine ChAdOx1 MERS
رقم بروتوكول الدراسة
CT18/004/R
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz Medical City NG (Riyadh)
مرحلة الدراسة
1
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。